ZipLine makes former Peak leader John Tighe CEO
This article was originally published in Clinica
Executive Summary
ZipLine Medical, a California company developing noninvasive surgical skin closure technology called PRELOC, has appointed John Tighe president and CEO. Mr Tighe previously headed up PEAK Surgical, a specialist in surgical incision devices, which Medtronic acquired for $105m last year (www.clinica.co.uk, 8 July 2011). Before joining PEAK in 2006, Mr Tighe was senior vice-president and general manager of another surgical firm, Arthrocare. ZipLine's PRELOC technology can be used in procedures including caesareans, laparotomy and pacemaker implantation; the firm estimates that it could address a $4.2bn worldwide market. Its ZipLine 15 and ZipLine 3 products are both classed as Class I, exempt devices so are subject to the least stringent regulatory control. Meanwhile, Campbell-based ZipLine closed a $5m Series B fundraising round, taking total investment in the company to $6m.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.